Ukr.Biochem.J. 2021; Volume 93, Issue 2, Mar-Apr, pp. 72-81

doi: https://doi.org/10.15407/ubj93.02.072

The association between vitamin D status and cardiometabolic disorders in overweight and obese adolescents

18.05.2021   Uncategorized   No comments

H. A. Pavlyshyn, A.-M. A. Shulhai*

Department of Pediatrics № 2, I. Horbachevsky Ternopil National Medical University, Ternopil, Ukraine;
*e-mail: shulhai_aa@tdmu.edu.ua

Received: 29 January 2021; Accepted: 23 April 2021

An increase in the prevalence of overweight and obese adolescents is often combined with a low level of vitamin D that may be associated with lipid and carbohydrate metabolism disorders, which underlie the development of arterial hypertension and cardiometabolic changes. This work aimed to determine the association between vitamin D status and the main parameters of lipid and carbohydrate metabolism, and anthropometric measurements. A total of 196 adolescents (129 boys and 67 girls) from the Ternopil region were examined. Their mean age was 15.5 ± 2.3 years. Based on the body mass index (BMI): 60 adolescents had normal body weight, 60 were overweight, and 76 were obese. Anthropometric measurements and general examinations were performed. In blood serum 25(OH)D levels and the main parameters of lipid and carbohydrate metabolism were determined. Low levels of 25(OH)D were found. Prevalence of vitamin D deficiency among adolescents with BMI up to the 85th percentile was 56.7%, with BMI in the 85-97th percentiles was 70.0% and with BMI over the 97th percentile was 77.6%. Serum 25(OH)D levels in overweight and obese adolescents had a significant correlation with BMI (r = -0.427, P < 0.001), waist circumference (r = -0.462, P < 0.001), high-density lipoprotein cholesterol (HDL-C, r = 0.214, P = 0.023), low-density lipoprotein cholesterol (LDL-C, r = -0.226, P = 0.011), atherogenic index (r = -0.284, P = 0.001), insulin level (r = -0.483, P < 0.001), and HOMA-IR index (r = -0.454, P < 0.001). We concluded that the development of cardiometabolic disorders in overweight and obese adolescents is associated with vitamin D status.

Keywords: , , ,

References:

  1. Wang Y, Lim H. The global childhood obesity epidemic and the association between socio-economic status and childhood obesity. Int Rev Psychiatry. 2012;24(3):176-188. PubMed, PubMedCentral, CrossRef
  2. Lartey ST, Magnussen CG, Si L, Boateng GO, de Graaff B, Biritwum RB, Minicuci N, Kowal P, Blizzard L, Palmer AJ. Rapidly increasing prevalence of overweight and obesity in older Ghanaian adults from 2007-2015: Evidence from WHO-SAGE Waves 1 & 2. PLoS One. 2019;14(8):e0215045. PubMed, PubMedCentral, CrossRef
  3. Shulhai AMA, Pavlyshyn HA, Shulhai OM. Peculiarities of the prevalence and risk factors for vitamin D deficiency in overweight and obese adolescents in Ukraine. Arch Balk Med Union. 2019;54(1):57-63.  CrossRef
  4. Holick MF. The vitamin D deficiency pandemic: Approaches for diagnosis, treatment and prevention. Rev Endocr Metab Disord. 2017;18(2):153-165. PubMed, CrossRef
  5. Mata-Greenwood E, Huber HF, Li C , Nathanielsz PW. Role of pregnancy and obesity on vitamin D status, transport, and metabolism in baboon. Am J Physiol Endocrinol Metab. 2019;316(1):E63-E72. PubMed, PubMedCentral, CrossRef
  6. Hingorani  AD, Finan C, Schmidt AF. Obesity causes cardiovascular diseases: adding to the weight of evidence. Eur Heart J. 2020;41(2):227-230. PubMed,CrossRef
  7. Akil L, Ahmad HA. Relationships between obesity and cardiovascular diseases in four southern states and Colorado. J Health Care Poor Underserved. 2011;22(4 Suppl):61-72. PubMed, PubMedCentral, CrossRef
  8. Shulhai AM, Pavlyshyn H, Shulhai O. Relation of carbohydrate exchange markers with vitamin D status in adolescents with overweight and obesity. Pediatr Endocrinol Diabetes Metab. 2019;25(4):169-176. PubMed, CrossRef
  9. Atabek ME, Eklioglu BS, Akyürek N, Alp H. Association between vitamin D level and cardiovascular risk in obese children and adolescents. J Pediatr Endocrinol Metab. 2014;27(7-8):661-666. PubMed, CrossRef
  10. Bandera Merchan B, Morcillo S, Martin-Nuñez G, Tinahones, FJ, Macías-González M. The role of vitamin D and VDR in carcinogenesis: Through epidemiology and basic sciences. J Steroid Biochem Mol Biol. 2017;167:203-218. PubMed, CrossRef
  11. Abbas MA. Physiological functions of Vitamin D in adipose tissue. J Steroid Biochem Mol Biol. 2017;165(Pt B):369-381. PubMed, CrossRef
  12. Bischoff-Ferrari HA. Relevance of vitamin D in muscle health. Rev Endocr Metab Disord. 2012;13(1):71-77. PubMed, CrossRef
  13. Kirk EP, Klein S. Pathogenesis and pathophysiology of the cardiometabolic syndrome. J Clin Hypertens (Greenwich). 2009;11(12):761-765. PubMed, PubMedCentral, CrossRef
  14. Childhood overweight and obesity. World Health Organization [Internet]. 2020. Available from: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight.
  15. Flynn JT, Kaelber DC, Baker-Smith CM, Blowey D, Carroll AE, Daniels SR, de Ferranti SD, Dionne JM, Falkner B, Flinn SK, Gidding SS, Goodwin C, Leu MG, Powers ME, Rea C, Samuels J, Simasek M, Thaker VV, Urbina EM. Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents. Pediatrics. 2017;140(3):e20171904.  PubMed, CrossRef
  16. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM, Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911-1930. PubMed, CrossRef
  17. Povoroznyuk VV, Balatska NI. Vitamin D deficiency in the population of Ukraine and the risk factors for its development. Pain, Joints, Spine. 2012; (4.08): 5-11.
  18. Pludowski P, Holick MF, Grant WB, Konstantynowicz J, Mascarenhas MR, Haq A, Povoroznyuk V, Balatska N, Barbosa AP, Karonova T, Rudenka E, Misiorowski W, Zakharova I, Rudenka A, Łukaszkiewicz J, Marcinowska-Suchowierska E, Łaszcz N, Abramowicz P, Bhattoa HP, Wimalawansa SJ. Vitamin D supplementation guidelines. J Steroid Biochem Mol Biol. 2018;175:125-135. PubMed, CrossRef
  19. Płudowski P, Karczmarewicz E, Bayer M, Carter G, Chlebna-Sokół D, Czech-Kowalska J, Dębski R, Decsi T, Dobrzańska A, Franek E, Głuszko P, Grant WB, Holick MF, Yankovskaya L, Konstantynowicz J, Książyk JB, Księżopolska-Orłowska K, Lewiński A, Litwin M, Lohner S, Lorenc RS, Lukaszkiewicz J, Marcinowska-Suchowierska E, Milewicz A, Misiorowski W, Nowicki M, Povoroznyuk V, Piotr Rozentryt, Rudenka E, Shoenfeld Y, Socha P, Solnica B, Szalecki M, Tałałaj M, Varbiro S, Żmijewski MA. Practical guidelines for the supplementation of vitamin D and the treatment of deficits in Central Europe – recommended vitamin D intakes in the general population and groups at risk of vitamin D deficiency. Endokrynol Pol. 2013;64(4):319-327. PubMed, CrossRef
  20. Jellinger PS, Handelsman Y, Rosenblit PD, Bloomgarden ZT, Fonseca VA, Garber AJ, Grunberger G, Guerin CK, Bell DSH, Mechanick JI, Pessah-Pollack R, Wyne K, Smith D, Brinton EA, Fazi S, Davidson M.. American Association of Clinical Endocrinologists and American College of Endocrinology Guidelines for management of dyslipidemia and prevention of cardiovascular disease. Endocr Pract. 2017;23(Suppl 2):1-87. PubMed, CrossRef
  21. Rao SS, Disraeli P, McGregor T. Impaired glucose tolerance and impaired fasting glucose. Am Fam Physician. 2004;69(8):1961-1968. PubMed
  22. Sethuraman U, Zidan MA, Hanks L, Bagheri M, Ashraf A. Impact of vitamin D treatment on 25 hydroxy vitamin D levels and insulin homeostasis in obese African American adolescents in a randomized trial. J Clin Transl Endocrinol. 2018;12:13-19. PubMed, PubMedCentral, CrossRef
  23. Smyczyńska J, Smyczyńska U, Stawerska R, Domagalska-Nalewajek H, Lewiński A, Hilczer M. Seasonality of vitamin D concentrations and the incidence of vitamin D deficiency in children and adolescents from central Poland. Pediatr Endocrinol Diabetes Metab. 2019;25(2):54-59. PubMed, CrossRef
  24. Vierucci F, Del Pistoia M, Fanos M, Erba P, Saggese G. Prevalence of hypovitaminosis D and predictors of vitamin D status in Italian healthy adolescents. Ital J Pediatr. 2014;40:54. PubMed, PubMedCentral, CrossRef
  25. Peterson CA, Belenchia AM. Vitamin D deficiency & childhood obesity: a tale of two epidemics. Mo Med. 2014;111(1):49-53. PubMed, PubMedCentral
  26. Cheng L. The Convergence of Two Epidemics: Vitamin D Deficiency in Obese School-aged Children. J Pediatr Nurs. 2018;38:20-26. PubMed, CrossRef
  27. Nair S. Vitamin D deficiency and liver disease. Gastroenterol Hepatol (NY). 2010;6(8):491-493. PubMed, PubMedCentral
  28. Vanlint S. Vitamin D and obesity. Nutrients. 2013;5(3):949-956. PubMed, PubMedCentral, CrossRef
  29. Gil Á, Plaza-Diaz J, Mesa  MD. Vitamin D: Classic and Novel Actions. Ann Nutr Metab. 2018;72(2):87-95. PubMed, CrossRef
  30. Sebo ZL, Rodeheffer MS. Assembling the adipose organ: adipocyte lineage segregation and adipogenesis in vivo. Development. 2019;146(7):dev172098. PubMed, PubMedCentral, CrossRef
  31. Narvaez CJ, Simmons KM, Brunton J, Salinero A, Chittur SV, Welsh JE. Induction of STEAP4 correlates with 1,25-dihydroxyvitamin D3 stimulation of adipogenesis in mesenchymal progenitor cells derived from human adipose tissue. J Cell Physiol. 2013;228(10):2024-2036. PubMed, CrossRef
  32. Jari M, Qorbani M, Moafi M, Motlagh ME, Keikha M, Ardalan G, Kelishadi R. Association of 25-hydroxy Vitamin D levels with indexes of general and abdominal obesity in Iranian adolescents: The CASPIAN-III study. J Res Med Sci. 2015;20(2):122-126. PubMed, PubMedCentral
  33. Klöting N, Blüher M. Adipocyte dysfunction, inflammation and metabolic syndrome. Rev Endocr Metab Disord. 2014;15(4):277-287. PubMed, CrossRef
  34. Erol M, Bostan Gayret Ö, Hamilçıkan Ş, Can E, Yiğit ÖL. Vitamin D deficiency and insulin resistance as risk factors for dyslipidemia in obese children. Arch Argent Pediatr. 2017;115(2):133-139. PubMed, CrossRef
  35. Moore CE, Liu Y. Elevated systolic blood pressure of children in the United States is associated with low serum 25-hydroxyvitamin D concentrations related to body mass index: National Health and Examination Survey 2007-2010. Nutr Res. 2017;38:64-70. PubMed, CrossRef
  36. McMullan CJ, Borgi L, Curhan GC, Fisher N, Forman JP. The effect of vitamin D on renin-angiotensin system activation and blood pressure: a randomized control trial. J Hypertens. 2017;35(4):822-829. PubMed, PubMedCentral, CrossRef
  37. Banzato C, Maffeis C, Maines  E, Cavarzere P, Gaudino R, Fava C, Minuz P, Boner A, Antoniazzi F. Hypovitaminosis D and nocturnal hypertension in obese children: an interesting link. J Hum Hypertens. 2014;28(6):360-366. PubMed, CrossRef
  38. Erdönmez D,  Hatun, Çizmecioğlu FM, Keser A. No relationship between vitamin D status and insulin resistance in a group of high school students. J Clin Res Pediatr Endocrinol. 2011;3(4):198-201. PubMed, PubMedCentral, CrossRef
  39. Durá-Travé T, Gallinas-Victoriano F, Peñafiel-Freire DM, Urretavizcaya-Martinez M, Moreno-González P, Chueca-Guindulain MJ. Hypovitaminosis D and Cardiometabolic Risk Factors in Adolescents with Severe Obesity. Children (Basel). 2020;7(2):10. PubMed, PubMedCentral, CrossRef
  40. Szymczak-Pajor I, Śliwińska A. Analysis of Association between Vitamin D Deficiency and Insulin Resistance. Nutrients. 2019;11(4):794. PubMed, PubMedCentral, CrossRef
  41. Maltsev SV, Mansurova GS. Metabolism of vitamin D and means of its main functions’ implementation. Practical Med. 2014;14(9): 12-19.
Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License.